Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015–2020

Author:

Jeyashree KathiresanORCID,Thangaraj Jeromie,Rade Kiran,Modi Bhavesh,Selvaraju Sriram,Velusamy Saravanakumar,Akhil Sasidharan,Vijayageetha Mathavaswami,Sudha Rani Dhanapal,Sabarinathan Ramasamy,Manikandanesan Sakthivel,Elumalai Rajalakshmi,Natarajan MeenakumariORCID,Joseph Bency,Mahapatra Amarendra,Shamim Almas,Shah Amar,Bhardwaj Ashok,Purty Anil,Vadera Bhavin,Sridhar Anand,Chowdhury Aniket,Shafie Asif,Choudhury Avijit,Dhrubjyoti Deka,Solanki Hardik,Sirmanwar Krushna,Khaparde Kshitij,Parmar Malik,Dahiya Nisha,Debdutta Parija,Ahmed Quazi,Ramachandran Ranjani,Prasad Ranjeet,Shinde Rohini,Baruah Rupali,Chauhan Sandeep,Bharaswadkar Sandip,Achanta Shanta,Sharath Burugina Nagaraja,Balakrishnan ShibuORCID,Chandra Shivani,Khumukcham Sophia,Mandal Sudarsan,Chalil Sumitha,Shah Vaibhav,Roddawar Venkatesh,Rao Raghuram,Sachdeva Kuldeep,Murhekar ManojORCID

Abstract

ObjectivesWe verified subnational (state/union territory (UT)/district) claims of achievements in reducing tuberculosis (TB) incidence in 2020 compared with 2015, in India.DesignA community-based survey, analysis of programme data and anti-TB drug sales and utilisation data.SettingNational TB Elimination Program and private TB treatment settings in 73 districts that had filed a claim to the Central TB Division of India for progress towards TB-free status.ParticipantsEach district was divided into survey units (SU) and one village/ward was randomly selected from each SU. All household members in the selected village were interviewed. Sputum from participants with a history of anti-TB therapy (ATT), those currently experiencing chest symptoms or on ATT were tested using Xpert/Rif/TrueNat. The survey continued until 30 Mycobacterium tuberculosis cases were identified in a district.Outcome measuresWe calculated a direct estimate of TB incidence based on incident cases identified in the survey. We calculated an under-reporting factor by matching these cases within the TB notification system. The TB notification adjusted for this factor was the estimate by the indirect method. We also calculated TB incidence from drug sale data in the private sector and drug utilisation data in the public sector. We compared the three estimates of TB incidence in 2020 with TB incidence in 2015.ResultsThe estimated direct incidence ranged from 19 (Purba Medinipur, West Bengal) to 1457 (Jaintia Hills, Meghalaya) per 100 000 population. Indirect estimates of incidence ranged between 19 (Diu, Dadra and Nagar Haveli) and 788 (Dumka, Jharkhand) per 100 000 population. The incidence using drug sale data ranged from 19 per 100 000 population in Diu, Dadra and Nagar Haveli to 651 per 100 000 population in Centenary, Maharashtra.ConclusionTB incidence in 1 state, 2 UTs and 35 districts had declined by at least 20% since 2015. Two districts in India were declared TB free in 2020.

Funder

Central TB division, Ministry of Health & Family Welfare, India

Publisher

BMJ

Subject

General Medicine

Reference20 articles.

1. National strategic plan for tuberculosis elimination 2017–2025, 2017. New Delhi. Available: https://tbcindia.gov.in/WriteReadData/NSP Draft 20.02.2017 1.pdf

2. India TB report 2020, 2020. New Delhi. Available: www.tbcindia.gov.in [Accessed 19 Apr 2021].

3. TB notification rates across parliamentary constituencies in India: a step towards data-driven political engagement;Pardeshi;Trop Med Int Health,2021

4. Golandaj JA , Naikar SK , Hallad JS . Trends and sub-national disparities in TB notifications in India: insights from HMIS data. Indian J Tuberc.doi:10.1016/J.IJTB.2021.04.005

5. Inverse sampling to study disease burden of leprosy;Aggarwal;Indian J Med Res,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3